Literature DB >> 33133629

Papillary tumor of the pineal region: a single-center experience.

Christian Malte Boßelmann1,2,3, Irina Gepfner-Tuma1,4, Jens Schittenhelm1,5, Cornelia Brendle1,6, Juergen Honegger1,3, Ghazaleh Tabatabai1,4.   

Abstract

Papillary tumor of the pineal region (PTPR) is a rare entity. Its clinical presentation is diverse, and establishing an accurate and timely diagnosis may be challenging. Treatment recommendations are based on the evidence level of case series. Recently, several key advances have been made for immunohistochemical characterization, molecular diagnostics, and neurosurgical treatment of PTPR. Here, we describe our single-center experience.
© The Author(s) 2020. Published by Oxford University Press on behalf of the Society for Neuro-Oncology and the European Association of Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  papillary neoplasm; papillary tumor of the pineal region

Year:  2020        PMID: 33133629      PMCID: PMC7571506          DOI: 10.1093/nop/npaa014

Source DB:  PubMed          Journal:  Neurooncol Pract        ISSN: 2054-2577


  25 in total

1.  Adjuvant temozolomide chemotherapy for treatment of papillary tumor of the pineal region.

Authors:  Martin Lorenzetti; Federica Motta; Rolando Campanella; Dario Bauer; Agnese Assi; Cesare Arienta; Sergio Maria Gaini; Manuela Caroli
Journal:  World Neurosurg       Date:  2011 Jul-Aug       Impact factor: 2.104

2.  Increased mitotic and proliferative activity are associated with worse prognosis in papillary tumors of the pineal region.

Authors:  Stephanie Heim; Rudi Beschorner; Michel Mittelbronn; Kathy Keyvani; Markus J Riemenschneider; Istvan Vajtai; Christian Hartmann; Till Acker; Ingmar Blümcke; Werner Paulus; Martin Hasselblatt
Journal:  Am J Surg Pathol       Date:  2014-01       Impact factor: 6.394

3.  Papillary tumor of the pineal region presenting with Foster Kennedy sign.

Authors:  Joyce N Mbekeani; Manzoor Ahmed; Maher I Hassounah; Khaled Abdulshafi; Selwa A Al Hazzaa; Hindi Al Hindi
Journal:  Hematol Oncol Stem Cell Ther       Date:  2015-07-07

Review 4.  A case of papillary tumor of the pineal region with a long clinical history: molecular characterization and therapeutic consideration with review of the literature.

Authors:  Dai Kamamoto; Hikaru Sasaki; Kentaro Ohara; Katsuhiro Mizutani; Kazunari Yoshida
Journal:  Brain Tumor Pathol       Date:  2016-07-29       Impact factor: 3.298

5.  Prognosis and histopathologic features in papillary tumors of the pineal region: a retrospective multicenter study of 31 cases.

Authors:  Michelle Fèvre-Montange; Martin Hasselblatt; Dominique Figarella-Branger; Laurent Chauveinc; Jacques Champier; Ghislaine Saint-Pierre; Luc Taillandier; Alix Coulon; Werner Paulus; François Fauchon; Anne Jouvet
Journal:  J Neuropathol Exp Neurol       Date:  2006-10       Impact factor: 3.685

6.  Papillary tumor of the pineal region.

Authors:  Tibor Boco; Sophie Aalaei; Michael Musacchio; Richard Byrne; Elizabeth Cochran
Journal:  Neuropathology       Date:  2007-12-05       Impact factor: 1.906

7.  Papillary tumors of the pineal region: case report.

Authors:  Elias Dagnew; Lauren A Langford; Frederick F Lang; Franco DeMonte
Journal:  Neurosurgery       Date:  2007-05       Impact factor: 4.654

8.  PTEN mutations and activation of the PI3K/Akt/mTOR signaling pathway in papillary tumors of the pineal region.

Authors:  Tobias Goschzik; Marco Gessi; Dorota Denkhaus; Torsten Pietsch
Journal:  J Neuropathol Exp Neurol       Date:  2014-08       Impact factor: 3.685

9.  Papillary tumor of the pineal region accompanied by Parinaud's syndrome: magnetic resonance imaging findings.

Authors:  Bruno Niemeyer de Freitas Ribeiro; Bernardo Carvalho Muniz; Nina Ventura; Emerson Leandro Gasparetto; Edson Marchiori
Journal:  Radiol Bras       Date:  2018 May-Jun

10.  Durable response to mTOR inhibition in a patient with relapsing papillary tumor of the pineal region.

Authors:  Mattias Belting; Anna Bång-Rudenstam; Elisabet Englund; Torsten Pietsch
Journal:  Neuro Oncol       Date:  2019-01-01       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.